Core Laboratories (NYSE: CLB ) reported earnings on Jan. 30. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Core Laboratories beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share increased.
Gross margins contracted, operating margins increased, net margins dropped.
Core Laboratories logged revenue of $254.5 million. The 10 analysts polled by S&P Capital IQ expected a top line of $246.3 million on the same basis. GAAP reported sales were 4.4% higher than the prior-year quarter's $243.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.17. The 12 earnings estimates compiled by S&P Capital IQ predicted $1.13 per share. GAAP EPS of $1.17 for Q4 were 5.4% higher than the prior-year quarter's $1.11 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 36.7%, 10 basis points worse than the prior-year quarter. Operating margin was 29.8%, 10 basis points better than the prior-year quarter. Net margin was 21.5%, 30 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $242.6 million. On the bottom line, the average EPS estimate is $1.12.
Next year's average estimate for revenue is $1.05 billion. The average EPS estimate is $4.98.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 581 members out of 592 rating the stock outperform, and 11 members rating it underperform. Among 136 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 135 give Core Laboratories a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Core Laboratories is hold, with an average price target of $119.55.
Is Core Laboratories the right energy stock for you? Read about a handful of timely, profit-producing plays on expensive crude in "3 Stocks for $100 Oil." Click here for instant access to this free report.
- Add Core Laboratories to My Watchlist.